DA32 Life Science Tech Acquisition Corp. (DALS) 은(는) 상장 기업입니다 금융 섹터의 Shell Companies 산업에서 운영. 본사 소재지는 New York City, NY, 미국. 현재 CEO는 Steven Kafka.
DALS 을(를) 보유 IPO 날짜 2021-07-28, 에 상장 NASDAQ Capital Marke, 시가총액 $264.2M.
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
